$134.38
0.53% yesterday
NYSE, Jun 27, 10:13 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$134.38
+1.44 1.08% 1M
+19.39 16.86% 6M
+21.27 18.80% YTD
+29.73 28.41% 1Y
+25.30 23.19% 3Y
+45.37 50.97% 5Y
+85.37 174.19% 10Y
+110.94 473.28% 20Y
NYSE, Closing price Fri, Jun 27 2025
+0.71 0.53%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Basic
Market capitalization
$233.8b
Enterprise Value
$240.2b
Net debt
$6.4b
Cash
$6.8b
Shares outstanding
1.7b
Valuation (TTM | estimate)
P/E
17.38 | 25.78
P/S
5.52 | 5.18
EV/Sales
5.67 | 5.32
EV/FCF
36.08
P/B
4.79
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.67% | 1.76%
Growth 1Y | 5Y
7.69% | 11.16%
Payout 1Y | 3Y
29.20% | 41.96%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$42.3b | $45.1b
EBITDA
$9.2b | $12.2b
EBIT
$7.4b
Net Income
$13.5b | $9.1b
Free Cash Flow
$6.7b
Growth (TTM | estimate)
Revenue
5.00% | 7.56%
EBITDA
7.85% | 37.09%
EBIT
12.00%
Net Income
139.82% | -32.32%
Free Cash Flow
35.22%
Margin (TTM | estimate)
Gross
56.10%
EBITDA
21.77% | 26.95%
EBIT
17.45%
Net
31.89% | 20.10%
Free Cash Flow
15.72%
Financial Health
Equity Ratio
58.55%
Return on Equity
28.12%
ROCE
10.80%
ROIC
19.70%
Debt/Equity
0.27
More
EPS
$7.73
FCF per Share
$3.83
Short interest
1.20%
Employees
114.00k
Rev per Employee
$370.00k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Abbott Laboratories forecast:

21x Buy
66%
11x Hold
34%

Analyst Opinions

32 Analysts have issued a Abbott Laboratories forecast:

Buy
66%
Hold
34%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
42,344 42,344
5% 5%
100%
- Direct Costs 18,589 18,589
3% 3%
44%
23,755 23,755
7% 7%
56%
- Selling and Administrative Expenses 11,748 11,748
6% 6%
28%
- Research and Development Expense 2,790 2,790
5% 5%
7%
9,217 9,217
8% 8%
22%
- Depreciation and Amortization 1,826 1,826
6% 6%
4%
EBIT (Operating Income) EBIT 7,391 7,391
12% 12%
17%
Net Profit 13,502 13,502
140% 140%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
The Motley Fool
about 2 hours ago
I don't know if we'll be riding in personal aircraft 20 years from now, like George Jetson did in the cartoon TV series. I don't know if artificial intelligence (AI) will replace millions of jobs.
Neutral
PRNewsWire
2 days ago
ABBOTT PARK, Ill., June 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens.
Positive
The Motley Fool
2 days ago
The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today